MedPath

ENTERASENSE LIMITED

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study

Not Applicable
Completed
Conditions
Upper Gastrointestinal Bleeding
Interventions
Device: PillSense System
First Posted Date
2022-11-30
Last Posted Date
2022-11-30
Lead Sponsor
EnteraSense Limited
Target Recruit Count
30
Registration Number
NCT05631639
Locations
🇨🇿

Fakultní nemocnice Olomouc (FNOL), Olomouc, Czechia

🇨🇿

Institut klinické a experimentální medicíny (IKEM),, Prague, Czechia

🇨🇿

Fakultní nemocnice Ostrava (FNO), Ostrava, Czechia

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study

Not Applicable
Completed
Conditions
Upper Gastrointestinal Bleeding
Interventions
Device: PillSense System
First Posted Date
2022-11-30
Last Posted Date
2022-11-30
Lead Sponsor
EnteraSense Limited
Target Recruit Count
10
Registration Number
NCT05631652
Locations
🇨🇿

Institut klinické a experimentální medicíny (IKEM),, Prague, Czechia

PillSense System for Detecting UGI Bleed

Not Applicable
Completed
Conditions
Upper Gastrointestinal Bleed
UGI Bleed
Upper Gastrointestinal Bleeding
Interventions
Diagnostic Test: PillSense
First Posted Date
2022-05-23
Last Posted Date
2023-10-26
Lead Sponsor
EnteraSense Limited
Target Recruit Count
131
Registration Number
NCT05385224
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath